Correctly timed coasting reduces the risk of ovarian hyperstimulation syndrome and gives good cycle outcome in an in vitro fertilization program

被引:18
作者
Grochowski, D [1 ]
Wolczynski, S [1 ]
Kuczynski, W [1 ]
Domitrz, J [1 ]
Szamatowicz, J [1 ]
Szamatowicz, M [1 ]
机构
[1] Med Univ Bialystok, Dept Gynecol, IVF Unit, PL-15276 Bialystok, Poland
关键词
coasting; in vitro fertilization; ovarian hyperstimulation syndrome; pregnancy rate;
D O I
10.1080/713602832
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
One hundred and twelve severely overstimulated in vitro fertilization /intracytoplasmic sperm injection (IVF/ICSI) patients were treated with coasting when estradiol concentration was > 3000 pg/ml and the leading follicles had attained greater than or equal to 18 mm in diameter. Gonadotropin withholding war offered to them as a promising method for the prevention of both cycle cancellation and complications associated with severe ovarian hyperstimulation syndrome (OHSS). The duration of prolonged coasting prior to human chorionic gonadotropin (hCG) administration ranged from 2 to 9 days (mean 3.5). hCG was administered when the serum estradiol dropped to < 3000 pg/ml and at least three growing follicles greater than or equal to 20 mm in diameter were present. Fertilization failure was noted in six couples and in another 10 cases freezing of all embryos was decided, therefore embryo transfer was performed on 96 patients. There were 31 clinical pregnancies (five twins) giving a pregnancy rate per patient and per embryo transfer of 30.4% and 32.3%, respectively, with an implantation rate of 18.1%. With regard to all 112 coasted patients, six developed moderate and two severe OHSS. This study shows that withholding gonadotropin administration in high-risk IVF patients results in a good cycle outcome and a very low risk of severe OHSS, and also demonstrates the importance of both the timing of coasting initiation and the timing of hCG administration.
引用
收藏
页码:234 / 238
页数:5
相关论文
共 15 条
[1]   THE USE OF INTRAVENOUS ALBUMIN IN PATIENTS AT HIGH-RISK FOR SEVERE OVARIAN HYPERSTIMULATION SYNDROME [J].
ASCH, RH ;
IVERY, G ;
GOLDSMAN, M ;
FREDERICK, JL ;
STONE, SC ;
BALMACEDA, JP .
HUMAN REPRODUCTION, 1993, 8 (07) :1015-1020
[2]   Elective cryopreservation of all embryos in women at risk of developing ovarian hyperstimulation syndrome may not prevent the condition but reduces the live birth rate [J].
Awonuga, AO ;
Pittrof, RJ ;
Zaidi, J ;
Dean, N ;
Jacobs, HS ;
Tan, SL .
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 1996, 13 (05) :401-406
[3]  
BASSIL S, 1995, ASSIST REPROD REV, V5, P90
[4]  
BELAISCHALLART J, 1988, FERTIL STERIL, V50, P654
[5]   Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome [J].
Benadiva, CA ;
Davis, O ;
Kligman, I ;
Moomjy, M ;
Liu, HC ;
Rosenwaks, Z .
FERTILITY AND STERILITY, 1997, 67 (04) :724-727
[6]   THE SIGNIFICANCE OF 17-BETA-ESTRADIOL LEVELS IN HIGHLY RESPONDING WOMEN DURING OVULATION INDUCTION IN IVF TREATMENT - ITS IMPACT AND PROGNOSTIC VALUE WITH RESPECT TO OOCYTE MATURATION AND TREATMENT OUTCOME [J].
BENNUN, I ;
SHULMAN, A ;
GHETLER, Y ;
SHILON, M ;
KANETI, H ;
BEYTH, Y .
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 1993, 10 (03) :213-215
[7]   Timed unilateral ovarian follicular aspiration prior to administration of human chorionic gonadotrophin for the prevention of severe ovarian hyperstimulation syndrome in in-vitro fertilization: a prospective randomized study [J].
Egbase, PE ;
Makhseed, M ;
Al Sharhan, M ;
Grudzinskas, JG .
HUMAN REPRODUCTION, 1997, 12 (12) :2603-2606
[8]  
Golan A, 1989, Obstet Gynecol Surv, V44, P430, DOI 10.1097/00006254-198906000-00004
[9]  
GROCHOWSKI D, 1995, J ASSIST REPROD GEN, V12, P6
[10]   INTRAVENOUS ALBUMIN DOES NOT PREVENT THE DEVELOPMENT OF SEVERE OVARIAN HYPERSTIMULATION SYNDROME IN AN IN-VITRO FERTILIZATION PROGRAM [J].
NG, E ;
LEADER, A ;
CLAMAN, P ;
DOMINGO, M ;
SPENCE, JEH .
HUMAN REPRODUCTION, 1995, 10 (04) :807-810